Interferon-α drives T cell-mediated immunopathology in the intestine

European Journal of Immunology

Volumn 31, Issue 8, 2001, Pages 2247-2255

  Monteleone, Giovanni ^a,b   Pender, Sylvia L F ^a,c   Wathen, Neville C ^a   MacDonald, Thomas T ^a,b,c  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^b ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

^c SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

Author keywords

Celiac disease; IFN ; STAT

Indexed keywords

ALPHA INTERFERON; CD3 ANTIGEN; GAMMA INTERFERON; GELATINASE A; GLUTEN; INTERSTITIAL COLLAGENASE; POLYCLONAL ANTIBODY; PROTEIN TYROSINE KINASE; STAT1 PROTEIN; STAT3 PROTEIN; STROMELYSIN; T LYMPHOCYTE RECEPTOR; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; AUTOIMMUNITY; CELIAC DISEASE; CELL HYPERPLASIA; CONTROLLED STUDY; CRYPT CELL; DISEASE EXACERBATION; ENTEROPATHY; EXPLANT; FETUS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOPATHOLOGY; INTESTINE MUCOSA; INTESTINE VILLUS ATROPHY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TH1 CELL; TISSUE CULTURE; TISSUE INJURY;

ANTIGENS, CD3; CELIAC DISEASE; DNA-BINDING PROTEINS; FIBROBLAST GROWTH FACTOR 7; FIBROBLAST GROWTH FACTORS; HUMANS; HYPERPLASIA; INTERFERON TYPE II; INTERFERON-ALPHA; INTESTINAL MUCOSA; INTESTINES; LYMPHOCYTE ACTIVATION; MATRIX METALLOPROTEINASES; ORGAN CULTURE TECHNIQUES; PHOSPHORYLATION; PHOSPHOTYROSINE; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-FYN; RNA, MESSENGER; SRC-FAMILY KINASES; STAT1 TRANSCRIPTION FACTOR; STAT3 TRANSCRIPTION FACTOR; TH1 CELLS; TISSUE INHIBITOR OF METALLOPROTEINASES; TRANS-ACTIVATORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0034843855     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/1521-4141(200108)31:8<2247::AID-IMMU2247>3.0.CO;2-4     Document Type: Article

References (46)

1. Immunomodulation and therapeutic effects of the oral use of interferon-α: Mechanism of action
2. Cytokine therapeutics: Lessons from interferon α
3. + T cells
4. IFN-α and IFN-β: A link between immune memory and chronic inflammation
5. IFN-α 2B enhances Th1 cytokine responses in bladder cancer patients receiving Mycobacterium bovis bacillus Calmette-Guerin immunotherapy
6. Induction of type I diabetes by interferon-alpha in transgenic mice
7. Exacerbation of symptoms of autoimmune disease in patients receiving alpha-interferon therapy
8. Interferon-alpha therapy associated with the development of sarcoidosis
9. The pathogenesis of celiac disease
10. Current concepts of celiac disease pathogenesis
11. Gluten induces an intestinal cytokine response strongly dominated by interferon gamma in patients with celiac disease
12. Role of interferon-alpha in promoting T helper cell type 1 response in the small intestine in celiac disease
13. Celiac disease during interferon treatment
14. Evidence that activated mucosal T cells play a role in the pathogenesis of enteropathy in human small intestine
15. T cell activation can induce either mucosal destruction or adaptation in cultured human fetal small intestine
16. A major role for matrix metalloproteinases in T cell injury in the gut
17. Enhancing lamina propria Th1 cell responses with interleukin 12 produces severe tissue injury
18. Interactions between stromal cell-derived keratinocyte growth factor and epithelial transforming growth factor in immune-mediated crypt cell hyperplasia
19. + T cells and tissue damage in human small intestine by the bacterial superantigen, Staphylococcus aureus enterotoxin B
20. Signals and signs for lymphocyte responses
21. STATs: Signal transducers and activators of transcription
22. Transcriptionally active STAT1 is required for the antiproliferative effects of both interferon alpha and interferon gamma
23. Signaling via the T cell antigen receptor induces phosphorylation of STAT1 on serine 727
24. Antigen receptor signal transduction: Activating and inhibitory antigen receptors regulate STAT1 serine phosphorylation
25. Direct association of STAT3 with the IFNAR-1 chain of the human type I interferon receptor
26. TCR stimulation by antibody and bacterial superantigen induces Stat3 activation in human T cells
27. Interferon-alpha activates multiple STAT proteins and upregulates proliferation-associated IL-2Ralpha, c-myc, and pim-1 genes in human T cells
28. Interaction of p59fyn with interferon-activated Jak kinases
29. Complex complexes: Signaling at the TCR
30. Type I IFNs and regulation of Th1 responses: Enigmas both resolved and emerge
31. T cells orchestrate intestinal mucosal shape and integrity
32. Cytokine modulation of intestinal epithelial cell restitution: Central role for transforming growth factor-β
33. Fibroblast growth factors modulate intestinal epithelial cell growth and migration
34. Interleukin 15 mediates epithelial changes in celiac disease
35. Targeted disruption of the mouse STAT1 gene results in compromised innate immunity to viral disease
36. Targeted disruption of the STAT1 gene in mice reveals unexpected physiologic specificity in the JAK-STAT signaling pathway
37. Type I IFN modulates innate and specific antiviral immunity
38. Angiotensin II-induced tyrosine phosphorylation of signal transducers and activators of transcription 1 is regulated by Janus-activated kinase 2 and Fyn kinases and mitogen-activated protein kinase phosphotase 1
39. T cell immunity to oral allergens
40. Human Peyer's patch T cells are sensitized to dietary antigen and display a T helper cell type 1 cytokine profile
41. Functional expression of Fas and Fas ligand on human gut lamina propria T lymphocytes
42. Interferon-β mediates stromal cell rescue of T cells from apoptosis
43. Rescue by cytokines of apoptotic cell death induced by IL-2 deprivation of human antigen-specific T cell clones
44. IFN-α induces autoimmune T cells through the induction of intracellular adhesion molecule-1 and B7.2
45. Transgenic expression of IFN-α in the central nervous system of mice protects against lethal neurotropic viral infection but induces inflammation and neurodegeneration
46. Bioactive interleukin-18 expression is up-regulated in Crohn's disease